Thursday, July 30, 2009

OKC Doctors Save Soldiers' Hands after Grenade, Runaway Generator Accidents

OKC Doctors Save Soldiers' Hands after Grenade, Runaway Generator Accidents

Army Soldiers Thank Dr. Houshang Seradge and Dr. Joel Frazier of Orthopedic Institute

Oklahoma City, OK (PRWEB) July 29, 2009 -- U.S. Army officials are expressing gratitude toDr. Houshang Seradge (http://www.ortho-ok.com/physicians/seradge.php) and Dr. Joel Frazier (http://www.ortho-ok.com/physicians/frazier.php) at theOrthopedic Institute of Oklahoma (http://www.ortho-ok.com/) for saving the hands of two soldiers wounded in training exercises this spring. The two Fort Sill soldiers were injured in separate incidents on April 28. Both soldiers were transported to the Orthopedic Institute where doctors performed emergency hand surgeries.

Corporal Michael Sullivan, 26, from Franklin, North Carolina, thought the fingers of his right hand would need to be amputated after it was sucked into a runaway generator around 6:30am. Sullivan was still in the emergency room at Ft. Sill the afternoon of the accident when Sergeant Michael Mayfield, 42 of Brooklyn, NY, was admitted after a practice grenade exploded in his hand.

"Both soldiers had extensive injuries to their hands," said Dr. Houshang Seradge. "Our main concern was to properly treat the wounds to prevent infection. Once that is accomplished you can begin the reconstruction process."

Sergeant Mayfield's injuries required immediate treatment by a hand specialist so the two officers were transported in an ambulance to Orthopedic Institute in south Oklahoma City. OI has long been a friend to the state's military operations. Along with Dr. Houshang Seradge, the institute was a 2008 Secretary of State Freedom Award Nominee. The Freedom Award celebrates employers who exceed requirements in supporting reserve troops in their service to our country. Doctor Seradge met the soldiers and provided initial emergency care and evaluation. Then, Dr. Joel Frazier provided surgical care to Sergeant Mayfield while Dr. Seradge worked to repair Corporal Sullivan's hand.

"When it first happened, it looked as though I was going to lose three of my fingers or lose the use them. But the skill and care I received from Dr. Seradge and Dr. Frazier is what saved my hand. I can't thank them enough," said Corporal Sullivan whose hand was caught in a generator.

Dr. Seradge worked on the extensive injuries to Corporal Sullivan's index, long and ring fingers including open wounds and a condition called mallet fingers, which is the result of overextension of the tendon in the last joint of a finger and prevents straightening of the finger. His treatment required wound care and reconstruction of extensor tendons and nail beds. "He literally shaved off the top of three fingers down to the bone and joint," said Dr. Seradge

Sergeant Mayfield arrived with acute open wounds and injuries that required amputation of the tip of the middle finger of the right hand. Massive swelling was released and several severe lacerations with exposed nerves and arteries were also treated and repaired. Dr. Joel Frazier tells us "The blast literally split open his hand between all the fingers and thumb web spaces."

"The exceptionally skilled surgical team that attended these soldiers' injuries immediately put the soldiers at ease and gave them the opportunity to resume their duties and continue their military careers," said Larry E. Martin, Jr. Lieutenant Colonel, US Army Commanding.

Both soldiers have returned to duty. They continue their rehabilitation at The Therapy Center. TTC is an outpatient rehabilitation center at the Orthopedic Institute. The soldiers will continue trips to Oklahoma City to continue care for several more months.

Media Contact:

Stacy Ingram-Gilchrist 405.609.6019

About Orthopedic Institute

Orthopedic Institute of Oklahoma, established by Houshang Seradge, M.D. in 1980, is a comprehensive orthopedic care clinic, hospital and surgery center offering the most sophisticated and newest technologies as well as the state's leading physicians all focused on patient-centered treatment. The institute provides comprehensive orthopedic care, rheumatology and pain management services. The physicians, therapists and staff at Orthopedic Institute are dedicated to improving the quality of life and health of our patients by advancing our medical expertise on how to prevent, diagnose and treat orthopedic diseases and conditions. Visit us at http://www.ortho-ok.com/.

###



Contact Information Kym Koch Thompson

4058318668



Long Term Improvement of Type 2 Diabetes With Bariatric Surgery

Long Term Improvement of Type 2 Diabetes With Bariatric Surgery

A new study presented at the 26th Annual Meeting of the American Society for Metabolic & Bariatric Surgery confirms that laparoscopic gastric banding surgery (LAGB) results in sustained weight loss as well as an 83% improvement or remission of Type 2 diabetes.

Toronto, Ontario (PRWEB) July 30, 2009 -- Laparoscopic adjustable gastric banding surgery (LAGB) not only results in sustained weight loss for morbidly obese patients, but it also provides an improvement or remission of Type 2 diabetes in 83% of the patients. This news, the results of a new study, was presented at the 26th Annual Meeting of the American Society of Metabolic & Bariatric Surgery (ASMBS). The event was held in Dallas, Texas, and Slimband (http://slimband.com/) was there to learn first-hand about the ground breaking study.

To date, this is the largest long-term study on the impact of gastric banding on diabetes. This study strongly suggests that there is a definite connection between diabetes and morbid obesity. The study noted that the patients who achieved and maintained a significant weight loss also realized the greatest remission of diabetes in a shorter time frame.

The study included 95 participants who ranged in age prior to surgery from 21 to 68 years, with an average BMI (Body Mass Index) of 46. Researchers from New York University (NYU) Medical Center conducted the study from January 2002 through January 2004. Approximately 88% of the patients were taking oral medications to control their diabetes and about 15% were using insulin. On average, the patients had been diagnosed with diabetes about 6 ½ years before surgery.

As routine follow up to the surgery, the patients' weight was monitored and blood tests were done. During the first year, researchers followed each patient on a monthly basis, and during the second year the follow-ups were every three months. After that, the follow-ups were annual unless more frequent visits were needed.

At the end of the five-year follow-up period the data clearly showed that in about 40% of patients, diabetes was in remission and in about 43% it was improved, which resulted in a combined improvement/remission rate of 83%.

The incidence of diabetes and obesity is on the rise and that has resulted in several studies for effective methods for sustaining weight loss and for diabetes remission. Bariatric surgery (http://slimband.com/about-slimband/surgeon) has been shown to be an excellent option for the treatment of morbid obesity as well as a way to improve type 2 diabetes (http://slimband.com/diabetes).

ASMBS is a non-profit organization that works to progressively move forward in the science of gastric banding surgery. This includes educating both medical professionals and the lay public about gastric banding surgery as the treatment of choice for morbid obesity. The ASMBS also educates regarding the risks and benefits of the surgery.

For additional information about laparoscopic adjustable gastric banding surgery, visit the Slimband (http://slimband.com/contact) website.

About Slimband:

Slimband® is one of the largest and most respected weight loss surgery and treatment centers in Canada. Slimband® specializes in reversible laparoscopic weight loss surgery with a unique aftercare program that includes nutritional counseling, coaching, fitness programs and fill adjustments. Clients benefit not only from safe, fast weight loss but also experience increased energy levels and the control or elimination of weight-aggravated conditions like heart disease, high cholesterol, and type 2 diabetes. Slimband® has helped more than 3,000 patients fulfill their dreams of looking and feeling their best.

###



Contact Information Lisa Borg

Slimband

http://slimband.com/

416.473.4636



Wednesday, July 29, 2009

Medical Transcription Service, MxSecure, Partners with CHV to Enhance Community Health Care

Medical Transcription Service, MxSecure, Partners with CHV to Enhance Community Health Care

Agreement with Community Health Ventures (CHV) makes leading medical transcription service, MxSecure, available to 7,000 member health centers, serving 18 million patients

Scottsdale, AZ, (PRWEB) July 28, 2009 - Community Health Ventures (CHV) and MxSecure, Inc. today announced an agreement that names MxSecure a preferred partner for the provision of digital dictation (http://www.mxsecure.com/solutions/index.htm), medical transcription (http://www.mxsecure.com/solutions/transcription.htm) and document management service to over 7,000 health centers nationally. This partnership showcases both organizations commitment to increase the adoption of electronic health records in community health centers.

"MxSecure is proud to be contributing to CHV's efforts to extend quality health care to the millions of those underserved all across the country," said MxSecure's President and CEO, Colin Christie. "We believe we can help community health centers provide higher quality, more efficient health services to their patients, and maintain more accurate patient records, all at a very affordable cost. That helps everyone."

"CHV is excited about the opportunity to work with MxSecure in promoting this necessary and quality service to health centers," said Gwen Siebert CHV's Chief Operating Officer. "We not only feel that health centers will gain a valued partner in MxSecure, but will save money in the process. All things considered, this will move health centers closer to their stated goals of high quality and affordable care provided in the most dignified manner."

MxTranscribe EHR (http://www.mxsecure.com/solutions/mxtranscribe_ehr.htm), MxSecure's digital medical transcription and document management software, will give community health centers rapid turnaround on their medical documents, online document management and secure 24/7 access to patient information. MxTranscribe EHR reduces costs, improves patient care, increases provider satisfaction and represents a strong first step towards electronic health records.

About CHV

Community Health Ventures (CHV) is the business development affiliate of the National Association of Community Health Centers (NACHC). Founded in 2000, CHV was created under the direction of health center leadership and tasked with creating workable solutions to the tremendous economic pressures facing today's health centers. By negotiating group purchasing agreements that achieve better pricing, service and contractual terms for the products and services health centers use on a daily basis, CHV helps health centers reduce costs and remain competitive. For more information visit: Community Health Ventures (http://www.communityhealthventures.com)

About MxSecure, Inc.

MxSecure, Inc. - the fastest growing provider of medical transcription services to medical practices as recognized by Inc. 5000 - serves thousands of health care providers in over 600 medical facilities nationwide. MxSecure clients include physician and group practices, community health centers and multi-state, multi-specialty clinics. The company's digital medical transcription and electronic document management system - MxTranscribe EHR™ - includes Internet-based access to files 24/7; online review and editing; single and dual electronic signature; key word search capabilities; distribution options for routing to network printers, faxing and secure e-mail; and detailed management reporting tools. MxTranscribe EHR™ also offers integrated speech understanding technology and is fully scalable to multiple clinic locations with no capital outlay required. MxSecure also offers MxNotes™, a user-friendly, internet-based transcription service designed exclusively for medical practices with fewer than three physicians. With MxNotes™ physicians can dictate, review and edit electronic transcriptions within 24 hours of signing up. For more information see MxSecure.com (http://www.MxSecure.com).

###



Contact Information HEATHER DONCH

MxSecure, Inc.

http://www.MxSecure.com

888-580-1010



Surgical Expertise At Northwest Community Hospital's New Center Provides Hope for Pancreatic Cancer Patients

Surgical Expertise At Northwest Community Hospital's New Center Provides Hope for Pancreatic Cancer Patients

Awareness of pancreatic cancer is rising as a number of high-profile patients undergo treatment for the disease, and unfortunately many more have succumbed to it. But the news about pancreatic cancer is not all bad. "Expertise is what matters in treating the disease," said Dr. Malcolm Bilimoria, director of the new Illinois Center for Pancreatic and Hepatobiliary Diseases at Northwest Community Hospital in Arlington Heights.

Arlington Heights, IL (PRWEB) July 30, 2009 -- The Illinois Center for Pancreatic and Hepatobiliary Diseases has opened its doors at Northwest Community Hospital (http://www.nch.org/medical-services/pancreas-health/marilyn.php)in Arlington Heights, giving new hope to pancreatic cancer patients.

The only center of its kind in Illinois, the new center's director is Dr. Malcolm Bilimoria, an expert on the surgical treatment of pancreatic cancer. Specifically, Dr. Bilimoria specializes in surgery of the pancreas with the goal being complete removal of the cancer. Thus far, he has performed almost 700 pancreatic surgeries.

    

"Expertise is what matters in treating the disease," Dr. Bilimoria said. He cites a study published in the New England Journal of Medicine in 2003 that shows that mortality rates were lower for high-volume surgeons and high-volume centers, and that this is particularly true with regard to pancreatic surgeries.

    

"This is a patient safety (http://www.nch.org/medical-services/pancreas-health/expertise.php) matter," he said. "Surgical volume should be part of any informed discussions patients have with their doctors." The new center at NCH will do more than 200 pancreatic surgeries this year.

    

Pancreatic cancer is the fourth-leading cause of cancer death in America, and is considered one of the deadliest cancers. This year, the American Cancer Society estimates there will be 42,500 new cases of pancreatic cancer and 35,000 deaths from the disease.

    

The pancreas is a gland about 12 inches long that is located deep in the abdomen. In general terms, it has two main functions: to help with digestion and to produce hormones that regulate sugar in the blood.

    

Pancreatic cancer begins when abnormal cells grow out of control within the pancreas. The types of cells involved in pancreatic cancer help determine the best treatment. There's cancer that forms in the pancreas ducts that help produce the digestive juices, and there's cancer that forms in the hormone-producing cells.

    

"Treatment of the disease is challenging because early detection is uncommon, the disease tends to be aggressive, and recurrence is likely," Dr. Bilimoria said. Pancreatic cancer is treated through chemotherapy, targeted drug therapy, radiation therapy and surgery.

"Surgery to remove a tumor offers the best chance for long-term control of all types of pancreatic cancer," Dr. Bilimoria said. "This is where experience counts, and it makes such a difference."

    

For more information about pancreatic cancer and the newIllinois Center for Pancreatic and Hepatobiliary Diseases (http://www.nch.org/medical-services/pancreas-health/index.php) at Northwest Community Hospital, visit nch.org/pancreas.

###



Contact Information Blaine Krage

Northwest Community Hospital

http://www.NCH.org

847-618-5516



Tuesday, July 28, 2009

Valve Repair First in New England Done With Robotic Device

Valve Repair First in New England Done With Robotic Device

Alfred man chooses innovation after counseling from Patient Advocates (http://www.patientadvocatesllc.com/) in Gray.

Gray, ME (PRWEB) July 28, 2009 -- A York County man recently became the first person in New England to undergo a robot-assisted repair of the valve that allows blood into the heart, with support from a Maine company that helps patients select and obtain the best-possible treatment for serious conditions.

Thomas Holland of Alfred, Maine, received the mitral valve repair surgery at Massachusetts General Hospital, after consulting with health professionals at Patient Advocates (http://www.patientadvocatesllc.com/) in Gray, Maine. The procedure, using the da Vinci Surgical System, had never previously been performed in New England.

During the eight-hour procedure, Dr. Arvind Agnihotri viewed the surgical area as a three-dimensional environment, magnified to 10 times its actual size. Agnihotri, a cardiac surgeon, controlled the da Vinci's actions through small, highly precise hand and wrist motions.

Holland chose the procedure after learning from nurse-advocates at Patient Advocates that the technique is less invasive than traditional surgery, which requires a much-larger incision and the splitting of the breastbone for access to the heart. The robot-assisted surgical option, which involves tiny incisions between ribs, also can reduce the risk of infection, minimize blood loss and cut recovery times by weeks.

"I know other people who have had valve surgery without the robot, and they have a lot longer recovery times. I feel like I could go back to work today," said Holland, a welder at The Baker Co. in Sanford. "The doctors didn't even have to give me one of those heart-shaped pillows that they tell people to hold against their chest when they cough to keep from breaking open. I don't have the big hole in my chest that most patients do."

As Holland was considering whether to choose this procedure, nurse advocates at Patient Advocates gathered technical data, spoke with medical professionals at Massachusetts General and produced other research for him. Patient Advocates administers The Baker Co. self-insurance health plan, and medical advocacy is a core service provide to the members of such plans.

"Patients deserve access to the most leading-edge procedures available, which is why we work so closely with centers of medical excellence such as Massachusetts General," said Jim Ward, president and founder of Patient Advocates. "Not only is careful treatment research and analysis the right thing to do for patients, that advocacy also can create substantial cost savings.

"When patients receive the right care, they get healthy and return to work as quickly as possible," Ward said. "You don't have the expensive and unnecessary secondary treatments that happen when things aren't done right the first time."

Many members of health plans administered by Patient Advocates travel to centers of medical excellence for treatment, and patients receive support throughout that process.

"We often travel to Boston with patients to help them navigate the health care system. They appreciate that we're working to make sure everything goes smoothly," said Rosemary Simmons, RN, a nurse-advocate at Patient Advocates. "In this case, Tom felt comfortable enough with the procedure, after learning about it and seeing the research, that he didn't feel like he needed to have someone with him."

In recent days, Holland has been taking his boat out on the ocean to check on lobster traps. He has nothing but praise for the medical professionals he worked with at the hospital and Patient Advocates.

"They answered all my questions and made me feel really comfortable," he said. "I've never been in the hospital before, but they made the process easy. I'm glad I had the information I needed to choose this procedure."

About Patient Advocates

Patient Advocates LLC (http://www.patientadvocatesllc.com/) has been helping clients navigate the health care system since 1995. Employers trust PA to help manage their costs while ensuring the highest quality of care for their employees. Built on the premise that access to the highest quality health care results in greater cost-savings over time, Patient Advocates offers innovative patient advocacy and disease management services, award-winning wellness programs and creative benefit plan designs with third-party administration.

# # #



Contact Information Eric Blom

Broadreach Public Relations

http://www.patientadvocatesllc.com

207-846-3826



Huntsville, Alabama Plastic Surgeon David L. Durst, MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market

Huntsville, Alabama Plastic Surgeon David L. Durst, MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market

It’s been since November of 2006 since the FDA approved silicone breast implants for use in most breast augmentation and breast reconstruction procedures. One Huntsville, Alabama plastic cosmetic surgeon (http://www.drdurst.net/html/about.html) reflects on the benefits of the decision and discusses why he believes silicone offers a safe, more natural-looking alternative to saline implants.

(Vocus) July 28, 2009 -- In 2006, the U.S. Food and Drug Administration approved the use of silicone breast implants for breast augmentation in women over 22 and breast reconstruction procedures for women of any age. This decision came after years of rigorous study to examine the safety of the implants after controversy in the early 1990’s caused them to be pulled from the market. Dr. David L. Durst is cofounder of a Huntsville, Alabama cosmetic plastic surgery (http://www.drdurst.net/index.html) practice. During the moratorium on silicone breast implants, Dr. Durst participated in the FDA’s adjunct study on their safety. Dr. Durst says now that the implants have been approved for widespread use, he thinks that patients have an option that offers them many benefits. “At this point in time, the data suggests that silicone implants are every bit as safe as saline implants. There are some slight differences between the implants, and in some patients silicone and saline implants will work equally well, but there are clearly some situations where silicone implants work better.”

Dr. Durst says silicone implants feel more natural than their saline counterparts, and are less prone to visible wrinkling and rippling. He says since the FDA’s approval, there has been a progressive increase in the percentages of silicone implants utilized across the country, his own practice in particular. “It is in the 60-70% range. Most patients can see and feel the difference between the silicone and saline implants and are choosing what I believe to be the more natural option.”

Dr. Durst has even had quite a few of his Huntsville, Alabama breast augmentation (http://www.drdurst.net/html/breast.html) patients convert their saline implants to silicone for a more natural look and feel. He says although all medical implants can carry some associated risks, extensive studies were performed over a number of years and that silicone implants were determined to be just as safe as saline implants, and they do not seem to cause any unusual medical diseases or cancer. “At this point, I think we can say that silicone implants are every bit as safe as saline implants and certainly as safe as almost all medical implants.”

Dr. Durst gives each person considering breast augmentation or breast reconstruction an extensive overview of the procedure at the patient’s initial consultation, providing them with silicone implants to hold and feel so they can compare them to saline implants. He also uses this time to describe the risks and benefits of both implants and address any concerns the patient may have. Dr. Durst says that, in general, his patients have been extremely satisfied with silicone implants. “Ultimately, I think that, long-term, the benefits of utilizing silicone implants will be confirmed in more and more patients, resulting in a more widespread use in the future.”

About David L. Durst, MD

Dr. David L. Durst is certified by the American Board of Plastic Surgery, and is a member of the American Board of Plastic Surgery. He has been in private practice since 1987, and is co-founder of the Cosmetic Surgery Center of Huntsville, a facility certified by the American Association for Accreditation of Ambulatory Surgery Facilities. The AAAASF if the leading accreditation organization for office surgery – only facilities which adhere to the highest standards of safety and care are certified.

For more information on breast implants in Huntsville, Alabama (http://www.drdurst.net/html/breast.html), Dr. Durst can be reached at 4011 Balmoral Dr., Huntsville, Alabama 35801 – (256) 881-4200, or via his website at www.drdurst.net.

###



Contact Information David L. Durst, M.D.

David L. Durst, M.D.

http://www.drdurst.net

(256) 881-4200



Saturday, July 25, 2009

Study Suggests VELscope System Helps Reduce Recurrence of Oral Cancer

Study Suggests VELscope System Helps Reduce Recurrence of Oral Cancer

A high percentage of oral cancer patients experience a recurrence of the disease following surgery. The VELscope system uses fluorescence visualization technology to allow doctors to see cancerous and precancerous tissue that is beneath the surface and invisible to the naked eye. A new study tracking oral cancer patients indicated that none of the patients whose surgeons used the VELscope to determine which tissue to remove has experienced a recurrence of the disease. In contrast, 32% of the patients whose surgeon did not use the VELscope have experienced a recurrence of cancer or severe dysplasia.

White Rock, British Columbia (PRWEB) July 25, 2009 -- LED Dental Inc. announced today that a recent study suggests that its VELscope screening system (www.velscope.com) can help surgeons reduce the recurrence rate for oral cancer following surgery.

The article, "Tracing the 'At-Risk' Oral Mucosa Field with Autofluorescence: Steps Toward Clinical Impact," was just published in the journal Cancer Prevention Research. It was authored by Catherine F. Poh, Calum E. MacAulay and Miriam Rosin of the BC Cancer Agency and Lewei Zhang of the University of British Columbia. The study was prompted by numerous previous studies showing that oral cancer recurs in a significant percentage of patients following oral cancer surgery.

The study examined the experience of 60 oral cancer surgery patients between 2004 and 2008. Their cancerous lesions were treated with surgical excision alone, with a minimum follow-up time of 12 months. For 38 of the 60 patients, the surgeon used a surgical margin that was 10 mm beyond the tumor edge defined by the VELscope exam. Because the VELscope system utilizes fluorescence visualization, or FV, technology, these patients are described in the article as having had FV-guided surgery. The remaining 22 patients--the control group--did not have FV-guided surgery; instead, the surgeon used a surgical margin that was 10 mm beyond the tumor edge defined by the standard white-light exam. White light exams rely on visual inspection with the naked eye, whereas the VELscope system allows clinicians to discover cancerous and precancerous tissue that might not be apparent to the naked eye.

Four years into the study, severe dysplasia or more serious tumors have recurred in 7, or 32%, of the 22 control group patients. In contrast, none of the 38 FV-guided group patients has suffered a recurrence of severe dysplasia or more serious tumors, including cancer.

"The VELscope system is the first adjunctive device cleared by both the FDA and Health Canada to help surgeons determine the appropriate surgical margin," said Ralph Green, D.D.S., M.B.A., president and CEO of LED Dental's parent, LED Medical Diagnostics. "While the findings of this study are not surprising, it is nonetheless gratifying to have these respected researchers report that absolutely zero of the 38 oral cancer patients whose surgical margins were determined using the VELscope system has experienced a recurrence of this deadly and disfiguring disease." Dr. Green added, "Numerous other studies, as well as extensive feedback from our users, have documented the ability of the VELscope system to help dental practitioners discover cancerous and precancerous lesions that otherwise would have been missed. This new study suggests that in addition to enhancing the detection of oral cancer, the VELscope system can help ensure that all targeted diseased tissue is removed when surgical excision is indicated."

Oral cancer claims the life of one North American every hour of every day. Despite the reduction in the use of tobacco products, it is one of the few types of cancer that has not experienced a significant reduction in the number of victims over the past several decades. Recent studies suggest that the reason is a link between oral cancer and the sexually-transmitted human papilloma virus, or HPV. As a result, many health experts recommend that all adults receive oral cancer examinations on at least an annual basis.

Introduced to the dental market approximately three years ago, the VELscope system is already used for more oral cancer examinations than any other adjunctive technology in the world. Since its introduction, over 4,500 systems have been sold worldwide, and over 4.5 million VELscope examinations have been conducted. LED Dental estimates that over 3 million examinations, which are completely non-invasive and take only 2-to-3 minutes, will be conducted in 2009 alone.

The tissue fluorescence visualization technology platform on which the VELscope system is based is the culmination of over $50 million in research funded by the National Institutes of Health and other respected institutions and conducted by such leading organizations as the BC Cancer Agency and the University of Texas's M.D. Anderson Cancer Center. The VELscope system also helps clinicians discover non-cancerous types of oral mucosal abnormalities.

For more information, please visit http://www.velscope.com.

Contact:

John Pohl

LED Dental

847.812.2879

http://www.velscope.com

###



Contact Information John Pohl

LED Dental

http://www.velscope.com

847.812.2879